Treponema pallidum Antibody, IgM, Immunoassay, Cerebrospinal Fluid

What This Test Measures

The test detects immunoglobulin M (IgM) antibodies directed against Treponema pallidum in cerebrospinal fluid (CSF). IgM antibodies are an early-response type of antibody, so their presence can be relevant when evaluating active or recent infection. The measurement is performed using an immunoassay method on a CSF specimen.

Why It Is Ordered

A clinician may order this test when there are concerns about neurosyphilis — syphilis affecting the brain or spinal cord — especially when blood tests or symptoms suggest infection and a CSF sample has been collected. It is typically part of a broader evaluation that includes CSF cell counts, protein levels, and other syphilis tests rather than a stand-alone diagnosis.

How the Sample Is Collected

The specimen is cerebrospinal fluid, obtained through a lumbar puncture (spinal tap). A small amount of fluid is withdrawn from the lower back and sent to the laboratory. The procedure is performed by a clinician and usually takes a short time, though you may be asked to lie flat afterward for a period to reduce the chance of headache.

How Results Are Interpreted

Results are reported as reactive or nonreactive, or as detected/not detected, depending on the laboratory. A reactive result can support the possibility of central nervous system syphilis, while a nonreactive result makes it less likely but does not rule it out on its own. Because antibody tests can produce occasional false results, findings are interpreted together with symptoms, physical examination, imaging, and other CSF and blood tests.